ZDHHC3 and central nervous system cancer: IHC staining of the glioma surgical specimen also indicated that ZDHHC3 expression was higher in WHO III-IV glioma than in WHO II glioma and was higher in recurrent GBM than in primary GBM (Supplementary Fig. 2E, F).